Epigenetic Dominance of Prion Conformers
Although they share certain biological properties with nucleic acid based infectious agents, prions, the causative agents of invariably fatal, transmissible neurodegenerative disorders such as bovine spongiform encephalopathy, sheep scrapie, and human Creutzfeldt Jakob disease, propagate by conformational templating of host encoded proteins. Once thought to be unique to these diseases, this mechanism is now recognized as a ubiquitous means of information transfer in biological systems, including other protein misfolding disorders such as those causing Alzheimer's and Parkinson's diseases. To address the poorly understood mechanism by which host prion protein (PrP) primary structures interact with distinct prion conformations to influence pathogenesis, we produced transgenic (Tg) mice expressing different sheep scrapie susceptibility alleles, varying only at a single amino acid at PrP residue 136. Tg mice expressing ovine PrP with alanine (A) at (OvPrP-A136) infected with SSBP/1 scrapie prions propagated a relatively stable (S) prion conformation, which accumulated as punctate aggregates in the brain, and produced prolonged incubation times. In contrast, Tg mice expressing OvPrP with valine (V) at 136 (OvPrP-V136) infected with the same prions developed disease rapidly, and the converted prion was comprised of an unstable (U), diffusely distributed conformer. Infected Tg mice co-expressing both alleles manifested properties consistent with the U conformer, suggesting a dominant effect resulting from exclusive conversion of OvPrP-V136 but not OvPrP-A136. Surprisingly, however, studies with monoclonal antibody (mAb) PRC5, which discriminates OvPrP-A136 from OvPrP-V136, revealed substantial conversion of OvPrP-A136. Moreover, the resulting OvPrP-A136 prion acquired the characteristics of the U conformer. These results, substantiated by in vitro analyses, indicated that co-expression of OvPrP-V136 altered the conversion potential of OvPrP-A136 from the S to the otherwise unfavorable U conformer. This epigenetic mechanism thus expands the range of selectable conformations that can be adopted by PrP, and therefore the variety of options for strain propagation.
Vyšlo v časopise:
Epigenetic Dominance of Prion Conformers. PLoS Pathog 9(10): e32767. doi:10.1371/journal.ppat.1003692
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1003692
Souhrn
Although they share certain biological properties with nucleic acid based infectious agents, prions, the causative agents of invariably fatal, transmissible neurodegenerative disorders such as bovine spongiform encephalopathy, sheep scrapie, and human Creutzfeldt Jakob disease, propagate by conformational templating of host encoded proteins. Once thought to be unique to these diseases, this mechanism is now recognized as a ubiquitous means of information transfer in biological systems, including other protein misfolding disorders such as those causing Alzheimer's and Parkinson's diseases. To address the poorly understood mechanism by which host prion protein (PrP) primary structures interact with distinct prion conformations to influence pathogenesis, we produced transgenic (Tg) mice expressing different sheep scrapie susceptibility alleles, varying only at a single amino acid at PrP residue 136. Tg mice expressing ovine PrP with alanine (A) at (OvPrP-A136) infected with SSBP/1 scrapie prions propagated a relatively stable (S) prion conformation, which accumulated as punctate aggregates in the brain, and produced prolonged incubation times. In contrast, Tg mice expressing OvPrP with valine (V) at 136 (OvPrP-V136) infected with the same prions developed disease rapidly, and the converted prion was comprised of an unstable (U), diffusely distributed conformer. Infected Tg mice co-expressing both alleles manifested properties consistent with the U conformer, suggesting a dominant effect resulting from exclusive conversion of OvPrP-V136 but not OvPrP-A136. Surprisingly, however, studies with monoclonal antibody (mAb) PRC5, which discriminates OvPrP-A136 from OvPrP-V136, revealed substantial conversion of OvPrP-A136. Moreover, the resulting OvPrP-A136 prion acquired the characteristics of the U conformer. These results, substantiated by in vitro analyses, indicated that co-expression of OvPrP-V136 altered the conversion potential of OvPrP-A136 from the S to the otherwise unfavorable U conformer. This epigenetic mechanism thus expands the range of selectable conformations that can be adopted by PrP, and therefore the variety of options for strain propagation.
Zdroje
1. SotoC (2012) Transmissible proteins: expanding the prion heresy. Cell 149: 968–977.
2. ForgetKJ, TremblayG, RoucouX (2013) p53 Aggregates Penetrate Cells and Induce the Co-Aggregation of Intracellular p53. PLoS One 8: e69242.
3. PrusinerSB (2012) Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336: 1511–1513.
4. TellingGC (2013) The importance of prions. PLoS Pathog 9: e1003090.
5. WillRG, IronsideJW, ZeidlerM, CousensSN, EstibeiroK, et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921–925.
6. GordonWS (1946) Advances in veterinary research. Vet Res 58: 516–520.
7. AgrimiU, RuG, CardoneF, PocchiariM, CaramelliM (1999) Epidemic of transmissible spongiform encephalopathy in sheep and goats in Italy. Lancet 353: 560–561.
8. PrusinerSB, ScottM, FosterD, PanK-M, GrothD, et al. (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673–686.
9. ScottM, GrothD, FosterD, TorchiaM, YangS-L, et al. (1993) Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73: 979–988.
10. KociskoDA, ComeJH, PriolaSA, ChesebroB, RaymondGJ, et al. (1994) Cell-free formation of protease-resistant prion protein. Nature 370: 471–474.
11. ClouscardC, BeaudryP, ElsenJM, MilanD, DussaucyM, et al. (1995) Different allelic effects of the codons 136 and 171 of the prion protein gene in sheep with natural scrapie. J Gen Virol 76 ((Pt 8)) 2097–2101.
12. BessenRA, MarshRF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68: 7859–7868.
13. TellingGC, ParchiP, DeArmondSJ, CortelliP, MontagnaP, et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274: 2079–2082.
14. KangHE, WengCC, SaijoE, SaylorV, BianJ, et al. (2012) Characterization of Conformation-Dependent Prion Protein Epitopes. J Biol Chem 287 ((44)): 37219–32.
15. HoustonEF, HallidaySI, JeffreyM, GoldmannW, HunterN (2002) New Zealand sheep with scrapie-susceptible PrP genotypes succumb to experimental challenge with a sheep-passaged scrapie isolate (SSBP/1). J Gen Virol 83: 1247–1250.
16. Dickinson AG, Outram GW, Taylor DM, Foster JD (1989) Further evidence that scrapie agent has an independent genome. In: Court LA, Dormont D, Brown P, Kingsbury DT, editors. Unconventional Virus Diseases of the Central Nervous System. Candé, France: L'Imprimerie Lefrancq et Cie. pp. 446–460.
17. FosterJD, DickinsonAG (1988) The unusual properties of CH 1641, a sheep-passaged isolate of scrapie. Vet Rec 123: 5–8.
18. HopeJ, WoodSC, BirkettCR, ChongA, BruceME, et al. (1999) Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH1641. J Gen Virol 80 ((Pt 1)) 1–4.
19. LegnameG, NguyenHO, PeretzD, CohenFE, DeArmondSJ, et al. (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A 103: 19105–19110.
20. GreenKM, CastillaJ, SewardTS, NapierDL, JewellJE, et al. (2008) Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog 4: e1000139.
21. AyersJI, SchuttCR, ShikiyaRA, AguzziA, KincaidAE, et al. (2011) The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog 7: e1001317.
22. DeleaultNR, WalshDJ, PiroJR, WangF, WangX, et al. (2012) Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A 109: E1938–1946.
23. TaraboulosA, JendroskaK, SerbanD, YangS-L, DeArmondSJ, et al. (1992) Regional mapping of prion proteins in brains. Proc Natl Acad Sci USA 89: 7620–7624.
24. AngersRC, KangHE, NapierD, BrowningS, SewardT, et al. (2010) Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 328: 1154–1158.
25. SaborioGP, PermanneB, SotoC (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810–813.
26. CastillaJ, SaaP, HetzC, SotoC (2005) In vitro generation of infectious scrapie prions. Cell 121: 195–206.
27. WestawayD, DeArmondSJ, Cayetano-CanlasJ, GrothD, FosterD, et al. (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76: 117–129.
28. RubensteinR, BulginMS, ChangB, Sorensen-MelsonS, PetersenRB, et al. (2012) PrP(Sc) detection and infectivity in semen from scrapie-infected sheep. J Gen Virol 93: 1375–1383.
29. CrozetC, FlamantF, BencsikA, AubertD, SamarutJ, et al. (2001) Efficient transmission of two different sheep scrapie isolates in transgenic mice expressing the ovine PrP gene. J Virol 75: 5328–5334.
30. CrozetC, BencsikA, FlamantF, LezmiS, SamarutJ, et al. (2001) Florid plaques in ovine PrP transgenic mice infected with an experimental ovine BSE. EMBO Rep 2: 952–956.
31. VilotteJL, SoulierS, EssalmaniR, StinnakreMG, VaimanD, et al. (2001) Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp. J Virol 75: 5977–5984.
32. TamguneyG, MillerMW, GilesK, LemusA, GliddenDV, et al. (2009) Transmission of scrapie and sheep-passaged bovine spongiform encephalopathy prions to transgenic mice expressing elk prion protein. J Gen Virol 90: 1035–1047.
33. CordierC, BencsikA, PhilippeS, BetempsD, RonzonF, et al. (2006) Transmission and characterization of bovine spongiform encephalopathy sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59). J Gen Virol 87: 3763–3771.
34. ScottMR, KöhlerR, FosterD, PrusinerSB (1992) Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1: 986–997.
35. GoldmannW, HunterN, SmithG, FosterJ, HopeJ (1994) PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol 75: 989–995.
36. BaronT, BiacabeAG (2007) Molecular behaviors of “CH1641-like” sheep scrapie isolates in ovine transgenic mice (TgOvPrP4). J Virol 81: 7230–7237.
37. HunterN, FosterJD, GoldmannW, StearMJ, HopeJ, et al. (1996) Natural scrapie in a closed flock of Cheviot sheep occurs only in specific PrP genotypes. Archives of virology 141: 809–824.
38. GonzalezL, JeffreyM, DagleishMP, GoldmannW, SisoS, et al. (2012) Susceptibility to scrapie and disease phenotype in sheep: cross-PRNP genotype experimental transmissions with natural sources. Vet Res 43: 55.
39. GreenKM, BrowningSR, SewardTS, JewellJE, RossDL, et al. (2008) The elk PRNP codon 132 polymorphism controls cervid and scrapie prion propagation. J Gen Virol 89: 598–608.
40. WadsworthJD, AsanteEA, DesbruslaisM, LinehanJM, JoinerS, et al. (2004) Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306: 1793–1796.
41. CollingeJ, ClarkeAR (2007) A general model of prion strains and their pathogenicity. Science 318: 930–936.
42. Dickinson AG, Outram GW (1979) The scrapie replication-site hypothesis and its implications for pathogenesis. In: Prusiner SB, Hadlow WJ, editors. Slow Transmissible Diseases of the Nervous System, Vol 2. New York: Academic Press. pp. 13–31.
43. BruceME, McConnellI, FraserH, DickinsonAG (1991) The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72: 595–603.
44. DickinsonAG, FraserH, McConnellI, OutramGW, SalesDI, et al. (1975) Extraneural competition between different scrapie agents leading to loss of infectivity. Nature 253: 556.
45. ShikiyaRA, AyersJI, SchuttCR, KincaidAE, BartzJC (2010) Coinfecting prion strains compete for a limiting cellular resource. J Virol 84: 5706–5714.
46. MansonJC, ClarkeAR, HooperML, AitchisonL, McConnellI, et al. (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8: 121–127.
47. CastillaJ, MoralesR, SaaP, BarriaM, GambettiP, et al. (2008) Cell-free propagation of prion strains. EMBO J 27: 2557–2566.
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2013 Číslo 10
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Dengue Vaccines: Strongly Sought but Not a Reality Just Yet
- MicroRNA-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb
- Alternative Roles for CRISPR/Cas Systems in Bacterial Pathogenesis
- RNA Biology in Fungal Phytopathogens